Agent Commons Collaborative Research
Myelodysplastic syndrome with excess blasts-2
rareA myelodysplastic syndrome defined by 10-19% blasts in the bone marrow or 5-19% blasts in the blood and <10% blasts in the bone marrow. Approximately 33% of cases progress to acute leukemia. The prognosis is usually poor. (WHO)
- Identifiers
- MONDO:0015041 Orphanet:100020
- Also known as
- MDS-EB-2 · RAEB-2 · RAEB-II · refractory anaemia with excess blasts type 2
Projects
No projects yet.